SANTA BARBARA, California, September 9, 2020 / PRNewswire / – Direct Relief has committed $2. 5 million to expand its bloodless chain pharmaceutical distribution capacity, preparing to lend a hand to the public fitness government and other fitness partners in the global distribution of VACCINEs for COVID-19.
The $ 2. 5 million investment aims to triple Direct Relief’s medical refrigeration and freezing capacity. Direct Relief’s recently validated bloodless store for vaccines can hold up to 40 million doses of vaccine in a 10-dose package consistent with the vial at the typical temperature consistent with a range of 2 to 8 degrees Celsius, but lacks a freezing capacity greater than some COVID. 19 vaccinations may be required. The organization is in talks with national and state fitness authorities, the National Association of Pharmaceutical Boards, and Pharmaceutical Donors about plans to distribute the COVID-19 vaccine.
Direct Relief is one of the world’s leading channels for charitable drug distribution, adding vaccines and other bloodless chain drugs (those that require constant, conscientiously controlled refrigeration), to others who would not otherwise be there. access. In the United States, Direct Relief is a central channel for the distribution of these drugs to non-profit safety net providers, adding network fitness centers. These providers are critical to reaching underserved communities, and in particular other people of color, who have been disproportionately affected by COVID-19.
Direct Relief’s pharmaceutical distribution center, which opened in 2018 in California, is one of 665 locations in the United States accredited through the National Association of Boards of Pharmacy as an accredited drug distributor and is the only one operated through a global humanitarian aid organization.
While the express temperature control needs for COVID-19 vaccines remain unknown, Direct Relief believes that the overall capacity of the bloodless chain is much lower than is mandatory for immediate mass immunization efforts to immunize the US population. America, let alone the world’s population.
“Direct Relief is taking this step urgently, detecting the pressures that exist to get the vaccine approved for others who want it safely,” said Thomas Tighe, President and CEO of Direct Relief. “Existing bloodless chain channels were not designed for this scale of activity. The scenario echoes serious problems with the allocation and distribution of PPE, which did not require a specialized license to manipulate, buy or track, as prescription drugs do. vaccines. “
Direct Relief has great delight in working with the world’s leading brands of medical products to distribute prescription drugs, vaccines and bloodless biological remedies similar to humanitarian and emergency reaction efforts. In the fiscal year ending June 30, Direct Relief delivered 2,103 bloodless chain deliveries of these products, managing end-to-end distribution for fitness services in the United States and 33 other countries. These deliveries included 738,000 insulin vials of Eli Lilly, Novo Nordisk and Sanofi for patients with type 1 and type 2 diabetes; Cancer drugs from Amgen, Teva, Takeda and Baxter; remedies for blood clotting hemophilia from Bayer, Takeda, Pfizer and Kedrion Biopharma; and Takeda and Biogen biological remedies for patients with rare genetic diseases.
Direct Relief has largely responded to COVID-19 since cases were first reported in January in Wuhan, China and the western United States. Since Direct Relief’s first COVID-19 aid delivery on January 27, the organization has sent 21,083 medical aid shipments to 2,786 fitness services in 54 US states and territories and 88 countries. These shipments contained 3. 2 million pounds. (1,600 tons) of essential medical parts, adding more than 38 million N95 and surgical masks, more than 7 million gloves, more than a million face shields, and tens of thousands of adjustments and other parts to assist fitness personnel and caring for patients, as well as 76. 9 million explained daily doses of drugs, valued at $ 747. 6 million (bulk acquisition cost).
“Since Direct Relief is a not-for-profit public enforcement organization with the specialized licenses, skills, and delight necessary to deliver bloodless vaccine chain, we will do everything in our power to compel public organizations that have more than complete ”. Tighe said. “We also want to make sure that those who want it most, who our organization is every day and who have been disproportionately affected through COVID-19, have a channel to them. “
About direct relief
Direct Relief, a humanitarian organization committed to the health and lives of others affected by poverty or emergencies, provides important medical resources around the world to communities in need, regardless of politics, faith or the ability to pay. For more information, visit https: //www. Direct Relief. org.
Watch the content to download multimedia: http://www. prnewswire. com/news-releases/direct-relief-prepares-for-covid-19-vaccine-distribution-committing-2-5-million-to-expand -cold – string capacity-301126791. html
SOURCE Direct Relief